Commonwealth Equity Services, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$2.88 - $4.3 $37,310 - $55,706	-12,955 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$3.72 - $5.35 $279 - $401	75 Added 0.58%	12,955 $54,000
Q2 2021 Aug 11, 2021	BUY	$3.83 - $5.98 $363 - $568	95 Added 0.74%	12,880 $68,000
Q1 2021 May 04, 2021	SELL	$3.33 - $8.76 $2,287 - $6,018	-687 Reduced 5.1%	12,785 $59,000
Q4 2020 Feb 11, 2021	SELL	$3.27 - $4.64 $719 - $1,020	-220 Reduced 1.61%	13,472 $44,000
Q3 2020 Nov 05, 2020	SELL	$3.23 - $4.3 $4,845 - $6,450	-1,500 Reduced 9.87%	13,692 $45,000
Q2 2020 Aug 12, 2020	SELL	$3.31 - $6.54 $1,324 - $2,616	-400 Reduced 2.57%	15,192 $51,000
Q1 2020 May 11, 2020	SELL	$2.9 - $6.16 $9,280 - $19,712	-3,200 Reduced 17.03%	15,592 $59,000
Q4 2019 Feb 05, 2020	BUY	$5.61 - $8.57 $3,927 - $5,999	700 Added 3.87%	18,792 $113,000
Q3 2019 Oct 30, 2019	BUY	$7.56 - $15.44 $34,776 - $71,024	4,600 Added 34.09%	18,092 $136,000
Q2 2019 Jul 19, 2019	BUY	$5.4 - $15.5 $72,856 - $209,126	13,492 New	13,492 $182,000
Q1 2019 May 13, 2019	SELL	$3.6 - $6.22 $51,912 - $89,692	-14,420 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$2.89 - $7.91 $41,673 - $114,062	14,420 New	14,420 $42,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.